 Paul Buehler
Concepts (331)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemoglobins | 49 | 2019 | 315 | 8.360 |
Why?
| | Haptoglobins | 19 | 2019 | 47 | 3.410 |
Why?
| | Oxygen | 20 | 2019 | 854 | 2.660 |
Why?
| | Blood Substitutes | 13 | 2012 | 27 | 2.470 |
Why?
| | Kidney | 12 | 2018 | 1188 | 1.460 |
Why?
| | Erythrocyte Transfusion | 6 | 2019 | 189 | 1.450 |
Why?
| | Erythrocytes | 10 | 2019 | 591 | 1.340 |
Why?
| | Oxidation-Reduction | 23 | 2019 | 923 | 1.120 |
Why?
| | Guinea Pigs | 15 | 2018 | 136 | 1.060 |
Why?
| | Homeostasis | 2 | 2019 | 573 | 0.990 |
Why?
| | Hemopexin | 4 | 2018 | 13 | 0.960 |
Why?
| | Oxyhemoglobins | 4 | 2019 | 20 | 0.840 |
Why?
| | Anemia, Sickle Cell | 4 | 2019 | 215 | 0.840 |
Why?
| | Iron | 12 | 2019 | 233 | 0.830 |
Why?
| | Ascorbic Acid | 6 | 2019 | 110 | 0.810 |
Why?
| | Oximetry | 2 | 2019 | 81 | 0.790 |
Why?
| | Hemolysis | 7 | 2018 | 146 | 0.780 |
Why?
| | Electron Spin Resonance Spectroscopy | 5 | 2019 | 86 | 0.770 |
Why?
| | Animals | 51 | 2019 | 31694 | 0.730 |
Why?
| | Hydrogen Peroxide | 10 | 2015 | 288 | 0.690 |
Why?
| | Apoproteins | 2 | 2019 | 12 | 0.660 |
Why?
| | Blood Preservation | 5 | 2019 | 263 | 0.660 |
Why?
| | Polymers | 5 | 2012 | 448 | 0.650 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 6 | 2013 | 53 | 0.650 |
Why?
| | Transferrin | 3 | 2015 | 39 | 0.630 |
Why?
| | Drug Design | 2 | 2010 | 148 | 0.600 |
Why?
| | Lipoproteins | 1 | 2018 | 159 | 0.580 |
Why?
| | Lipids | 2 | 2018 | 580 | 0.570 |
Why?
| | Receptors, Cell Surface | 6 | 2013 | 355 | 0.570 |
Why?
| | Heme | 8 | 2019 | 52 | 0.570 |
Why?
| | Acute Kidney Injury | 4 | 2018 | 637 | 0.560 |
Why?
| | Oxidative Stress | 11 | 2019 | 1076 | 0.560 |
Why?
| | Antigens, CD | 6 | 2013 | 442 | 0.550 |
Why?
| | Lipid Peroxidation | 8 | 2018 | 139 | 0.530 |
Why?
| | Biomarkers | 5 | 2019 | 3408 | 0.520 |
Why?
| | Hemochromatosis | 1 | 2015 | 9 | 0.490 |
Why?
| | beta-Globins | 1 | 2015 | 10 | 0.490 |
Why?
| | Nitric Oxide | 9 | 2018 | 823 | 0.470 |
Why?
| | Glutaral | 3 | 2012 | 14 | 0.450 |
Why?
| | Gene Deletion | 1 | 2015 | 356 | 0.430 |
Why?
| | Vascular Diseases | 2 | 2015 | 230 | 0.430 |
Why?
| | Blood Transfusion | 2 | 2015 | 293 | 0.430 |
Why?
| | Peroxidases | 3 | 2015 | 25 | 0.420 |
Why?
| | Transfusion Reaction | 2 | 2017 | 65 | 0.420 |
Why?
| | Rats | 14 | 2019 | 4958 | 0.420 |
Why?
| | Macrophages | 5 | 2019 | 1261 | 0.390 |
Why?
| | Hypertension, Pulmonary | 4 | 2019 | 1727 | 0.370 |
Why?
| | Receptors, Scavenger | 5 | 2013 | 16 | 0.360 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2011 | 249 | 0.350 |
Why?
| | Drug Carriers | 2 | 2008 | 112 | 0.350 |
Why?
| | Biopolymers | 1 | 2010 | 26 | 0.340 |
Why?
| | Cattle | 8 | 2012 | 920 | 0.330 |
Why?
| | Lung Diseases | 2 | 2015 | 701 | 0.330 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2015 | 134 | 0.330 |
Why?
| | Hypoxia | 6 | 2019 | 957 | 0.320 |
Why?
| | Heme Oxygenase (Decyclizing) | 5 | 2013 | 21 | 0.310 |
Why?
| | Lung | 3 | 2018 | 3558 | 0.310 |
Why?
| | Rats, Sprague-Dawley | 9 | 2018 | 2218 | 0.310 |
Why?
| | Signal Transduction | 4 | 2019 | 4509 | 0.290 |
Why?
| | Erythrocyte Indices | 2 | 2019 | 27 | 0.290 |
Why?
| | Erythropoiesis | 2 | 2019 | 33 | 0.290 |
Why?
| | Plasma Exchange | 1 | 2007 | 12 | 0.290 |
Why?
| | Uric Acid | 1 | 2008 | 148 | 0.280 |
Why?
| | Amino Acids | 3 | 2015 | 448 | 0.280 |
Why?
| | Spleen | 3 | 2015 | 487 | 0.280 |
Why?
| | Male | 26 | 2019 | 55554 | 0.270 |
Why?
| | Molecular Weight | 5 | 2012 | 331 | 0.270 |
Why?
| | Myocardium | 4 | 2019 | 913 | 0.270 |
Why?
| | Humans | 44 | 2019 | 114623 | 0.270 |
Why?
| | Inflammation | 2 | 2018 | 2477 | 0.270 |
Why?
| | Disease Models, Animal | 7 | 2019 | 3531 | 0.260 |
Why?
| | Blood Circulation | 1 | 2005 | 35 | 0.260 |
Why?
| | Vascular Remodeling | 2 | 2019 | 153 | 0.260 |
Why?
| | Models, Animal | 3 | 2018 | 344 | 0.250 |
Why?
| | Chromatography, Gel | 5 | 2010 | 122 | 0.240 |
Why?
| | Antioxidants | 1 | 2008 | 530 | 0.240 |
Why?
| | Aspirin | 2 | 2006 | 324 | 0.240 |
Why?
| | Heme Oxygenase-1 | 6 | 2018 | 52 | 0.240 |
Why?
| | Vascular Resistance | 2 | 2016 | 337 | 0.230 |
Why?
| | Nitrogen Oxides | 1 | 2004 | 47 | 0.230 |
Why?
| | Blood Pressure | 6 | 2018 | 1538 | 0.220 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 843 | 0.220 |
Why?
| | Hemoglobin A | 4 | 2006 | 21 | 0.220 |
Why?
| | Polyethylene Glycols | 2 | 2016 | 561 | 0.220 |
Why?
| | Endothelial Cells | 2 | 2011 | 681 | 0.210 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2015 | 154 | 0.210 |
Why?
| | Protein Engineering | 2 | 2018 | 98 | 0.210 |
Why?
| | Methemoglobin | 3 | 2015 | 19 | 0.200 |
Why?
| | Vasoconstriction | 3 | 2016 | 177 | 0.190 |
Why?
| | Methemoglobinemia | 2 | 2015 | 13 | 0.190 |
Why?
| | Models, Biological | 4 | 2018 | 1620 | 0.190 |
Why?
| | Cell Line | 6 | 2015 | 2635 | 0.190 |
Why?
| | Pulmonary Artery | 3 | 2019 | 1015 | 0.190 |
Why?
| | Liver | 3 | 2015 | 1634 | 0.190 |
Why?
| | Free Radicals | 4 | 2015 | 99 | 0.180 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 4689 | 0.180 |
Why?
| | Subarachnoid Space | 1 | 2019 | 8 | 0.170 |
Why?
| | Vasospasm, Intracranial | 1 | 2019 | 17 | 0.170 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2018 | 1842 | 0.170 |
Why?
| | Protein Unfolding | 1 | 2019 | 31 | 0.170 |
Why?
| | Biotechnology | 1 | 2019 | 41 | 0.170 |
Why?
| | Rats, Inbred Lew | 1 | 2019 | 91 | 0.160 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2019 | 60 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2019 | 68 | 0.160 |
Why?
| | Blotting, Western | 5 | 2015 | 1147 | 0.160 |
Why?
| | Erythropoietin | 2 | 2018 | 72 | 0.160 |
Why?
| | Ferritins | 2 | 2010 | 52 | 0.160 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2319 | 0.160 |
Why?
| | Toxicokinetics | 1 | 2018 | 9 | 0.160 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 35 | 0.160 |
Why?
| | Protein Binding | 5 | 2013 | 1889 | 0.160 |
Why?
| | Lipocalin-2 | 1 | 2018 | 61 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 168 | 0.160 |
Why?
| | Proteomics | 3 | 2019 | 836 | 0.150 |
Why?
| | Anemia | 1 | 2019 | 143 | 0.150 |
Why?
| | Kidney Function Tests | 1 | 2018 | 140 | 0.150 |
Why?
| | Treatment Outcome | 3 | 2019 | 9084 | 0.150 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 318 | 0.150 |
Why?
| | Hepcidins | 2 | 2015 | 21 | 0.150 |
Why?
| | Neutrophil Activation | 1 | 2018 | 94 | 0.150 |
Why?
| | Serine Endopeptidases | 1 | 2018 | 102 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2018 | 923 | 0.140 |
Why?
| | Microvessels | 1 | 2018 | 68 | 0.140 |
Why?
| | Physical Exertion | 1 | 2018 | 209 | 0.140 |
Why?
| | Solutions | 2 | 2010 | 146 | 0.140 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 275 | 0.140 |
Why?
| | Oxymorphone | 1 | 2016 | 3 | 0.140 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 30 | 0.140 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 172 | 0.140 |
Why?
| | Thrombotic Microangiopathies | 1 | 2016 | 12 | 0.140 |
Why?
| | Mice | 6 | 2019 | 14860 | 0.140 |
Why?
| | Hemodynamics | 2 | 2012 | 1012 | 0.130 |
Why?
| | Polymerization | 2 | 2018 | 119 | 0.130 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2018 | 89 | 0.130 |
Why?
| | Heart | 1 | 2019 | 612 | 0.130 |
Why?
| | Spin Trapping | 1 | 2015 | 3 | 0.130 |
Why?
| | Protein Stability | 3 | 2012 | 157 | 0.120 |
Why?
| | Splenomegaly | 1 | 2015 | 17 | 0.120 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 411 | 0.120 |
Why?
| | Muscle Contraction | 1 | 2018 | 389 | 0.120 |
Why?
| | Procollagen-Proline Dioxygenase | 2 | 2011 | 26 | 0.120 |
Why?
| | Nitrates | 1 | 2015 | 72 | 0.120 |
Why?
| | Hemorrhage | 1 | 2019 | 620 | 0.120 |
Why?
| | beta-Thalassemia | 1 | 2015 | 23 | 0.120 |
Why?
| | Cardiac Output | 2 | 2012 | 143 | 0.120 |
Why?
| | Altitude | 1 | 2018 | 432 | 0.120 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 141 | 0.120 |
Why?
| | Cation Transport Proteins | 1 | 2015 | 123 | 0.110 |
Why?
| | Transcriptome | 2 | 2018 | 725 | 0.110 |
Why?
| | Cross-Linking Reagents | 2 | 2012 | 181 | 0.110 |
Why?
| | Reactive Oxygen Species | 2 | 2007 | 531 | 0.110 |
Why?
| | Endotoxemia | 1 | 2014 | 85 | 0.110 |
Why?
| | Creatinine | 2 | 2012 | 425 | 0.110 |
Why?
| | Muscle Proteins | 1 | 2015 | 210 | 0.110 |
Why?
| | Malaria | 1 | 2013 | 48 | 0.100 |
Why?
| | Neutrophils | 1 | 2018 | 1176 | 0.100 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 30 | 0.100 |
Why?
| | Hematologic Diseases | 1 | 2012 | 55 | 0.100 |
Why?
| | Infusion Pumps | 1 | 2012 | 31 | 0.100 |
Why?
| | Osmotic Fragility | 1 | 2012 | 6 | 0.100 |
Why?
| | Spin Labels | 1 | 2012 | 44 | 0.100 |
Why?
| | Erythrocyte Deformability | 1 | 2012 | 12 | 0.100 |
Why?
| | Disease Progression | 2 | 2019 | 2380 | 0.100 |
Why?
| | Cardio-Renal Syndrome | 1 | 2012 | 10 | 0.100 |
Why?
| | Metabolic Clearance Rate | 1 | 2012 | 102 | 0.100 |
Why?
| | Recombinant Proteins | 3 | 2018 | 1230 | 0.100 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 347 | 0.100 |
Why?
| | Dimerization | 2 | 2010 | 176 | 0.100 |
Why?
| | Tyrosine | 1 | 2012 | 214 | 0.100 |
Why?
| | Catechin | 1 | 2011 | 23 | 0.100 |
Why?
| | Swine | 3 | 2019 | 700 | 0.100 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 16 | 0.090 |
Why?
| | Surface Plasmon Resonance | 2 | 2008 | 81 | 0.090 |
Why?
| | Area Under Curve | 1 | 2012 | 274 | 0.090 |
Why?
| | Proteome | 1 | 2015 | 339 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2018 | 3003 | 0.090 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2011 | 75 | 0.090 |
Why?
| | Dogs | 2 | 2009 | 334 | 0.090 |
Why?
| | Cell-Free System | 2 | 2007 | 47 | 0.090 |
Why?
| | Heart Diseases | 1 | 2014 | 331 | 0.090 |
Why?
| | Hypertension | 2 | 2009 | 1056 | 0.090 |
Why?
| | Microcirculation | 1 | 2011 | 135 | 0.090 |
Why?
| | Erythrocyte Aggregation | 1 | 2010 | 3 | 0.090 |
Why?
| | Pyridones | 1 | 2011 | 123 | 0.090 |
Why?
| | Filtration | 1 | 2010 | 59 | 0.090 |
Why?
| | Female | 9 | 2019 | 59466 | 0.090 |
Why?
| | Gene Expression | 1 | 2015 | 1421 | 0.080 |
Why?
| | Cellular Senescence | 1 | 2011 | 152 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2013 | 341 | 0.080 |
Why?
| | Biophysics | 1 | 2010 | 69 | 0.080 |
Why?
| | Pneumonia | 1 | 2015 | 567 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2016 | 771 | 0.080 |
Why?
| | Aorta | 1 | 2012 | 386 | 0.080 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2008 | 7 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1472 | 0.080 |
Why?
| | Globins | 1 | 2008 | 21 | 0.080 |
Why?
| | alpha-Globins | 1 | 2008 | 11 | 0.080 |
Why?
| | Cells, Cultured | 3 | 2015 | 3881 | 0.080 |
Why?
| | Cohort Studies | 1 | 2018 | 4894 | 0.080 |
Why?
| | Buffers | 1 | 2008 | 53 | 0.080 |
Why?
| | Models, Molecular | 2 | 2010 | 1369 | 0.080 |
Why?
| | Lasers | 2 | 2005 | 121 | 0.070 |
Why?
| | Ferric Compounds | 1 | 2008 | 41 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2017 | 411 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2009 | 157 | 0.070 |
Why?
| | Cytokines | 1 | 2015 | 1840 | 0.070 |
Why?
| | Tissue Engineering | 1 | 2011 | 364 | 0.070 |
Why?
| | Drug Stability | 1 | 2007 | 151 | 0.070 |
Why?
| | Adenosine Triphosphate | 2 | 2010 | 430 | 0.070 |
Why?
| | Binding Sites | 2 | 2011 | 1168 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2018 | 1862 | 0.070 |
Why?
| | Circular Dichroism | 1 | 2006 | 135 | 0.070 |
Why?
| | Methionine | 1 | 2006 | 144 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 502 | 0.070 |
Why?
| | Pentetic Acid | 1 | 2005 | 12 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 347 | 0.060 |
Why?
| | Molecular Structure | 1 | 2007 | 434 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2018 | 313 | 0.060 |
Why?
| | Cysteine | 1 | 2006 | 171 | 0.060 |
Why?
| | Time Factors | 2 | 2015 | 6112 | 0.060 |
Why?
| | Raffinose | 1 | 2005 | 18 | 0.060 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 115 | 0.060 |
Why?
| | Cystine | 1 | 2005 | 14 | 0.060 |
Why?
| | Coronary Vessels | 2 | 2018 | 227 | 0.060 |
Why?
| | Peptides | 1 | 2010 | 848 | 0.060 |
Why?
| | Scattering, Radiation | 1 | 2005 | 92 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2017 | 2186 | 0.060 |
Why?
| | Kinetics | 1 | 2008 | 1551 | 0.060 |
Why?
| | Chlorides | 1 | 2005 | 127 | 0.060 |
Why?
| | Particle Size | 1 | 2005 | 317 | 0.060 |
Why?
| | Heart Rate | 1 | 2007 | 709 | 0.060 |
Why?
| | Young Adult | 1 | 2018 | 10455 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 248 | 0.050 |
Why?
| | Piperidines | 1 | 2004 | 160 | 0.050 |
Why?
| | Risk Assessment | 1 | 2012 | 2967 | 0.050 |
Why?
| | Regional Blood Flow | 1 | 2004 | 424 | 0.050 |
Why?
| | Protein Conformation | 1 | 2005 | 805 | 0.050 |
Why?
| | Cell Movement | 1 | 2005 | 868 | 0.050 |
Why?
| | Cell Survival | 2 | 2018 | 1020 | 0.050 |
Why?
| | Nitrites | 2 | 2013 | 75 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1691 | 0.050 |
Why?
| | Adult | 2 | 2018 | 30528 | 0.040 |
Why?
| | Basilar Artery | 1 | 2019 | 6 | 0.040 |
Why?
| | Blood Banks | 1 | 2019 | 40 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 131 | 0.040 |
Why?
| | Cerebrospinal Fluid | 1 | 2019 | 90 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2019 | 53 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 470 | 0.040 |
Why?
| | Organ Culture Techniques | 1 | 2019 | 140 | 0.040 |
Why?
| | Gadolinium | 1 | 2019 | 73 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 176 | 0.040 |
Why?
| | Intracranial Aneurysm | 1 | 2019 | 91 | 0.040 |
Why?
| | Middle Aged | 1 | 2018 | 26719 | 0.040 |
Why?
| | Endothelins | 1 | 2018 | 61 | 0.040 |
Why?
| | Blood Safety | 1 | 2017 | 10 | 0.040 |
Why?
| | Finite Element Analysis | 1 | 2018 | 66 | 0.040 |
Why?
| | Hemodilution | 2 | 2008 | 10 | 0.040 |
Why?
| | Viscosity | 1 | 2018 | 81 | 0.040 |
Why?
| | Sheep | 1 | 2019 | 764 | 0.040 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 18 | 0.040 |
Why?
| | Acclimatization | 1 | 2018 | 149 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 1982 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2011 | 796 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1528 | 0.030 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 2006 | 15 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 993 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2016 | 159 | 0.030 |
Why?
| | Electric Impedance | 1 | 2015 | 100 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2015 | 2552 | 0.030 |
Why?
| | Biological Products | 1 | 2017 | 166 | 0.030 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2015 | 60 | 0.030 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2015 | 71 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 316 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2019 | 712 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 371 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 515 | 0.030 |
Why?
| | Mitochondria | 1 | 2019 | 747 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 322 | 0.030 |
Why?
| | Hemin | 1 | 2012 | 2 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2017 | 676 | 0.030 |
Why?
| | Lipoproteins, LDL | 1 | 2013 | 128 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 157 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 1214 | 0.030 |
Why?
| | Phagocytosis | 1 | 2014 | 350 | 0.030 |
Why?
| | Iron Metabolism Disorders | 1 | 2011 | 4 | 0.020 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2011 | 20 | 0.020 |
Why?
| | DNA Damage | 1 | 2014 | 351 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1518 | 0.020 |
Why?
| | Deferoxamine | 1 | 2011 | 18 | 0.020 |
Why?
| | Hydroxylation | 1 | 2011 | 29 | 0.020 |
Why?
| | Siderophores | 1 | 2011 | 9 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2011 | 99 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 561 | 0.020 |
Why?
| | Cobalt | 1 | 2011 | 46 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 511 | 0.020 |
Why?
| | Bioreactors | 1 | 2011 | 43 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 325 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 821 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2565 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2785 | 0.020 |
Why?
| | Hemoglobinuria | 1 | 2010 | 3 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 2796 | 0.020 |
Why?
| | Glucose Oxidase | 1 | 2010 | 18 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2010 | 192 | 0.020 |
Why?
| | Nitroso Compounds | 1 | 2009 | 5 | 0.020 |
Why?
| | Nitric Oxide Donors | 1 | 2009 | 15 | 0.020 |
Why?
| | Blood Component Transfusion | 1 | 2010 | 78 | 0.020 |
Why?
| | Canada | 1 | 2010 | 322 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2011 | 591 | 0.020 |
Why?
| | Glutathione | 1 | 2010 | 293 | 0.020 |
Why?
| | Sepsis | 1 | 2014 | 509 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2371 | 0.020 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 235 | 0.020 |
Why?
| | Nitric Oxide Synthase | 1 | 2008 | 209 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 740 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 220 | 0.020 |
Why?
| | Peroxides | 1 | 2006 | 20 | 0.020 |
Why?
| | Erythrocyte Membrane | 1 | 2006 | 50 | 0.020 |
Why?
| | Acute Disease | 1 | 2009 | 910 | 0.020 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2005 | 16 | 0.020 |
Why?
| | Osmotic Pressure | 1 | 2005 | 28 | 0.020 |
Why?
| | Rabbits | 1 | 2006 | 733 | 0.020 |
Why?
| | Apoptosis | 1 | 2014 | 2362 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2009 | 532 | 0.020 |
Why?
| | Endocytosis | 1 | 2005 | 148 | 0.010 |
Why?
| | Endosomes | 1 | 2005 | 124 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 345 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1313 | 0.010 |
Why?
| | United States | 1 | 2017 | 12176 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 665 | 0.010 |
Why?
| | Child | 1 | 2017 | 18404 | 0.010 |
Why?
|
|
Buehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|